The unique challenges, and need for awareness, of age-related macular degeneration (AMD) is now formally recognized in Canada ...

The new indication adds to the 2021 approval of Susvimo (ranibizumab) for 'wet' or neovascular age-related macular ...

The U.S. Food and Drug Administration has approved Susvimo (ranibizumab) 100 mg/mL for treating diabetic macular edema.

The adoption of telemedicine and remote monitoring technologies in ophthalmology to accelerate the market growth, says Fact.MR in its new market rese ...

Macular degeneration is one of the leading causes of vision loss, affecting millions worldwide, especially those over 60.

Dame Judi Dench has given an update on her failing eyesight due to macular disease, admitting that she can no longer leave the house unaccompanied. "Somebody will always be with me," she told Trinny ...

Our eyesight is essential to getting around, but if you’re not careful it can be seriously challenged by age-related macular ...

Macular degeneration is very common and affects an estimated 19.8 million people in the United States. Approximately one in 10 Americans age 50 and older have an early form of the disease and as many ...

The global macular degeneration treatment market size was valued at USD 10.06 billion in 2024 and it is projected to reach ...

Roche’s Susvimo receives US FDA approval for the treatment of diabetic macular edema: Basel Thursday, February 6, 2025, 11:00 Hrs [IST] Roche announced that the US Food and Drug ...

Apple Vision Pro brings relief to macular degeneration patients, with a daughter sharing how it improved her parent’s quality ...

The goal is to educate the public and professionals about AMD and support patients and families affected by vision impairment ...